52 / 100
Our CEO Kay Parkinson believes experts need to work together to address the unmet needs in rare disease research and treatment and abandon the siloed approach that fails patients and their families. Read her article her article from Pharmaphorum magazine here.
Cambridge Rare Disease Network - Rethinking rare diseases: treat the whole patient 1